bayesian inference
Recently Published Documents





2022 ◽  
Vol 148 (3) ◽  
Mansureh-Sadat Nabiyan ◽  
Hamed Ebrahimian ◽  
Babak Moaveni ◽  
Costas Papadimitriou

2022 ◽  
Vol 147 ◽  
pp. 105586
Marion Gödel ◽  
Nikolai Bode ◽  
Gerta Köster ◽  
Hans-Joachim Bungartz

2022 ◽  
Vol 246 ◽  
pp. 110571
Changbeom Kim ◽  
Selda Oterkus ◽  
Erkan Oterkus ◽  
Yooil Kim

2022 ◽  
Vol 172 ◽  
pp. 107304
José Aguiar Santos ◽  
José Ricardo Ferreira Oliveira ◽  
Jefferson Gomes do Nascimento ◽  
Ana Paula Fernandes ◽  
Gilmar Guimaraes

2022 ◽  
Vol 277 ◽  
pp. 107287
Nadine Berner ◽  
Martin H. Trauth ◽  
Matthias Holschneider

Viruses ◽  
2022 ◽  
Vol 14 (1) ◽  
pp. 157
Abhishek Mallela ◽  
Jacob Neumann ◽  
Ely F. Miller ◽  
Ye Chen ◽  
Richard G. Posner ◽  

Although many persons in the United States have acquired immunity to COVID-19, either through vaccination or infection with SARS-CoV-2, COVID-19 will pose an ongoing threat to non-immune persons so long as disease transmission continues. We can estimate when sustained disease transmission will end in a population by calculating the population-specific basic reproduction number , the expected number of secondary cases generated by an infected person in the absence of any interventions. The value of relates to a herd immunity threshold (HIT), which is given by . When the immune fraction of a population exceeds this threshold, sustained disease transmission becomes exponentially unlikely (barring mutations allowing SARS-CoV-2 to escape immunity). Here, we report state-level estimates obtained using Bayesian inference. Maximum a posteriori estimates range from 7.1 for New Jersey to 2.3 for Wyoming, indicating that disease transmission varies considerably across states and that reaching herd immunity will be more difficult in some states than others. estimates were obtained from compartmental models via the next-generation matrix approach after each model was parameterized using regional daily confirmed case reports of COVID-19 from 21 January 2020 to 21 June 2020. Our estimates characterize the infectiousness of ancestral strains, but they can be used to determine HITs for a distinct, currently dominant circulating strain, such as SARS-CoV-2 variant Delta (lineage B.1.617.2), if the relative infectiousness of the strain can be ascertained. On the basis of Delta-adjusted HITs, vaccination data, and seroprevalence survey data, we found that no state had achieved herd immunity as of 20 September 2021.

Sign in / Sign up

Export Citation Format

Share Document